Situm Blog

Situm rises a financing round with Amadeus and other investors

Situm rises a financing round with Amadeus and other investors

Amadeus Ventures, the corporate venture arm of the leading provider of technology solutions for tourism and travel sector, joins the Spanish company as a reference investor.

Situm has just incorporated Amadeus Ventures, the corporate venture arm of Amadeus IT group, as a new investor. Unirisco and Xesgalicia are also involved in this investment.

This way, Amadeus advances its goal of improving operations and performance across all parts of the travel sector, since Situm’s indoor positioning and navigation technology is an ideal solution for airports and train/bus stations’ users, removing the fear of unfamiliar and complex environments.

“When travelling, we often find ourselves in new places and unfamiliar surroundings, which can be daunting. By delivering a minimal infrastructure solution, and harnessing the power of personal mobile technology, we can quickly give travelers reassurance that they can always get to where they need to be” said Víctor Alvarez, CEO and founder of Situm

For airport or station operators, or conference or hotel owners, Situm allows real-time viewing of the user’s movements, facilitates better allocation of resources to smooth passenger flow, improves security services, and offers better analytics to improve geo-marketing and targeting.

“By working together with our own teams, developers and startups, we are focused on developing new ways to relieve the tensions that exist for all of us when travelling. Situm offers a really powerful solution and we look forward to having it as part of our investment portfolio and working together to solve some of these challenges”, said Katherine Grass, head of Amadeus Innovation and Ventures

With the participation of Unirisco and Xesgalicia

Amadeus makes this investment along with Unirisco and Xesgalicia. Unisirco is a venture capital company formed for the purpose of promoting the creation of companies that takes advantage of university knowledge.

Xesgalicia is a management company of venture capital entities that provides finance for enterprise development through several capital founds and compaines.

About Amadeus

Amadeus is a leading provider of advanced technology solutions for the global travel industry. Customer groups include travel providers (e.g. airlines, hotels, rail and ferry operators, etc.), travel sellers (travel agencies and websites), and travel buyers (corporations and travel management companies).

The Amadeus group employs around 15,000 people worldwide and does business in more than 190 countries. The company has central sites in Spain (corporate headquarters), France (development) and Germany (operations), and offices in 70 countries around the world.

Documents attached


Subscribe to our newsletter


Contact: Data controller:
Data protection officer:
Purpose and legal base: Sign-up for Situm Newsletter, only with consent.
Legitimation: Express consent of the interested party
Recipient: The data will not be transferred to third parties except for legal obligation.
Conservation period: As long as the interested party remain subscribed to SITUM newsletter (a link to unsubscribe is available in every newsletter that SITUM send).
Rights: The interested party may withdraw at any time their consent, as well as exercise their rights of objection, access, portability, rectification, limitation, data removal, and not to be the object of a decision based only on automated data processing, by writing to SITUM at the addresses specified.
Additional Information: You can find additional and detailed information on Data Protection in our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here. You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

Subscribing you accept the privacy informative and express your consent for the treatment”.